Welcome to our dedicated page for OLAPLEX HOLDINGS SEC filings (Ticker: OLPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Olaplex Holdings, Inc. filings document the formal disclosures of a Nasdaq-listed beauty company with common stock registered under the symbol OLPX. Recent Form 8-K reports cover results of operations and financial condition, including sales performance across professional, specialty retail, and direct-to-consumer channels and U.S. and international markets.
The filing record also documents material definitive agreements, capital-structure disclosures, shareholder voting matters, governance changes, and compensatory arrangements. Company-specific disclosures include the completed acquisition of Purvala Bioscience by an Olaplex subsidiary, board composition updates, and other material-event reporting tied to the company’s hair-care innovation and public-company obligations.
Catherine Dunleavy, Chief Operating Officer and Chief Financial Officer of Olaplex Holdings, Inc. (OLPX), reported the sale of 101,798 shares of Olaplex common stock on 08/14/2025 as a sell-to-cover transaction to satisfy tax withholding on vested restricted stock units. The weighted-average sale price was reported as $1.40. After the disposition, Ms. Dunleavy beneficially owns 1,966,848 shares, reported as direct ownership. The Form 4 was signed by an attorney-in-fact on 08/15/2025. The filing states the shares were sold in multiple transactions at prices ranging from $1.4001 to $1.4004.
Emily White, a director of Olaplex Holdings, Inc. (OLPX), was granted 110,294 restricted stock units (RSUs) on 08/12/2025 under the 2021 Equity Incentive Plan. Each RSU converts to one share and will vest in full at the company’s 2026 Annual Meeting only if Ms. White remains in service. The filing also reports sizable indirect beneficial ownership: 23,476,117 shares held by Anthos Capital IV, L.P., 148,064 shares held by Anthos Tribe, L.P., and 138,399 shares held by Anthos Management LP; Ms. White disclaims beneficial ownership except for any pecuniary interest. The form was signed by an attorney-in-fact on 08/14/2025.
Martha A. Morfitt, a director of Olaplex Holdings, Inc. (OLPX), was granted 110,294 restricted stock units (RSUs) on 08/12/2025. Each RSU converts to one share of common stock and the grant was reported with a $0 price. After the award the reporting person beneficially owned 402,833 shares directly and the reporting person’s spouse beneficially owned 9,000 shares indirectly. The RSUs will vest in full on the date of the issuer’s 2026 Annual Meeting of Stockholders, conditioned on the reporting person’s continued service through that date. The Form 4 was signed by attorney-in-fact John Duffy on 08/14/2025.
Olaplex Holdings insider grant of restricted stock units to a director. Director Jerome Griffith was granted 110,294 restricted stock units (RSUs) of Olaplex common stock on 08/12/2025 at no cash price. Each RSU represents a conditional right to one share and the award will vest in full on the date of the company’s 2026 Annual Meeting of Stockholders, subject to continued service. After the grant, the reporting person beneficially owns 110,294 shares on a direct basis related to these RSUs. The filing states the award was made under the Issuer’s 2021 Equity Incentive Plan.
Olaplex Holdings director Deirdre Findlay was granted 110,294 restricted stock units (RSUs) under the company's 2021 Equity Incentive Plan, reported on Form 4. Each RSU represents the conditional right to one share of common stock and was recorded as an acquisition on 08/12/2025 at no cash price. The RSUs will vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, contingent on the reporting person's continued service through the vesting date. The filing was signed by an attorney-in-fact on 08/14/2025 and includes a Power of Attorney exhibit.
Olaplex Holdings director Pamela J. Edwards received a grant of 110,294 restricted stock units (RSUs) on 08/12/2025. Each RSU represents the conditional right to one share of Olaplex common stock and was reported as issued at a $0 price. The RSUs are scheduled to vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to Ms. Edwards' continued service through that vesting date. Following the reported transaction, the reporting person beneficially owns 110,294 shares directly. The form was submitted via attorney-in-fact signature on 08/14/2025.
John P. Bilbrey, a director of Olaplex Holdings, Inc. (OLPX), received a grant of 294,118 restricted stock units (RSUs) on 08/12/2025. Each RSU converts into one share of common stock and the grant was recorded as an acquisition at $0 per RSU. After the grant, Mr. Bilbrey beneficially owns 640,021 shares in total, of which 318,418 shares are held indirectly through the Amended and Restated John P. Bilbrey Revocable Declaration of Trust. The RSUs vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, conditional on his continued service through that date. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
Olaplex Holdings, Inc. (OLPX) filed a Form 144 reporting a proposed sale of 108,335 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately 08/14/2025 on NASDAQ. The filing states these shares were acquired as restricted stock units on 08/13/2025 and were paid as compensation; the aggregate market value is $158,167.16 and the issuer’s shares outstanding are listed as 667,081,086, so the sale represents about 0.016% of outstanding stock. No securities were reported sold by the filer in the past three months. The filer affirms they are not aware of any undisclosed material adverse information.